RuvBL1/2 Gene Therapy for Motor Neurone Disease and Frontotemporal Dementia
Addressing DNA damage and protein aggregation to treat the most common genetic cause of MND/ALS and FTD
Published: 9th March 2021

Patents
- PCT/EP2021/052378 "Gene Therapy" Priority 12/02/2020
IP Status
- Patent application submitted
Seeking
- Development partner
- Commercial partner
- Seeking investment